Applied DNA SciencesAPDN
Market Cap: $14.9M
About: Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Employees: 55
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
6.14% less ownership
Funds ownership: 15.76% [Q1] → 9.62% (-6.14%) [Q2]
32% less funds holding
Funds holding: 28 [Q1] → 19 (-9) [Q2]
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
70% less capital invested
Capital invested by funds: $1.19M [Q1] → $354K (-$837K) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Yi Chen 32% 1-year accuracy 44 / 139 met price target | 3%upside $1.50 | Buy Maintained | 10 Jun 2024 |
Financial journalist opinion
Based on 6 articles about APDN published over the past 30 days